The core domain of hepatitis C virus glycoprotein E2 generates potent cross‐neutralizing antibodies in guinea pigs

A vaccine that prevents hepatitis C virus (HCV) infection is urgently needed to support an emerging global elimination program. However, vaccine development has been confounded because of HCV's high degree of antigenic variability and the preferential induction of type‐specific immune responses...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Hepatology
Hoofdauteurs: Vietheer, Patricia T., Boo, Irene, Gu, Jun, McCaffrey, Kathleen, Edwards, Stirling, Owczarek, Catherine, Hardy, Matthew P., Fabri, Louis, Center, Rob J., Poumbourios, Pantelis, Drummer, Heidi E.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: John Wiley and Sons Inc. 2017
Onderwerpen:
Viral Hepatitis
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5408392/
https://ncbi.nlm.nih.gov/pubmed/27997681
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hep.28989
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items